Drug Utilization in Very Premature Infants in Neonatal Intensive Care Units

Authors:
  • UBU. Bernsau
    U. Bernsau
  • MBM. Brand
    M. Brand
  • HHH.H. Hellwege
    H.H. Hellwege
  • GHG. Hieronimie
    G. Hieronimie
  • GJG. Jorch
    G. Jorch
  • HRH.L. Reiter
    H.L. Reiter
  • IVI.I. Versmold
    I.I. Versmold

Abstract
Neonatal drug utilization in very premature infants (gestational age (GA) 24-29 weeks), requiring intubation and mechanical ventilation at birth was registered as part of a multicenter controlled clinical trial of high-dose versus low-dose bovine surfactant (initial doses 100 mg/kg birth weight (b.w.) versus 50 mg/kg b.w.). Drug utilization during 4 weeks after birth was analyzed in 164 infants (mean GA 27.2 ± 1.2 (SD) weeks, b.w. 970 ± 145 g (SD)). More than half of the study infants received antibiotics (98.8%), sedatives and analgesics (91.5%), sodium bicarbonate (78%), solutions for volume replacement (62.8%), methylxanthines (56.7%) and catecholamines (52.4%). It may be concluded that the pattern of drug usage indicates a high incidence of proven or suspected infections and circulatory and respiratory disorders reflecting the high-risk state of study infants.